SENSS has substantial experience in reviewing and modelling breast cancer screening. We have conducted multiple projects that lead to published papers in high-impact publications.
Breast cancer is a disease where cells in the breast begin to grow and divide uncontrollably, forming a tumor. It typically originates in the milk ducts or the milk-producing glands. It is the most common cancer in women worldwide.
The necessity of breast cancer screening, primarily through routine mammography, lies in its ability to find cancer early, before symptoms are noticeable. A mammogram can detect very small, non-palpable cancers that are too tiny to be felt during a physical exam. Finding breast cancer at this localised, early stage means that treatment is often simpler, less invasive (e.g., less likely to require a full mastectomy), and significantly more likely to be successful. Regular screening is proven to reduce the number of deaths from breast cancer, ensuring that eligible individuals receive timely intervention and the best possible chance for a full recovery.
Cost-effectiveness model: ongoing (2024-2025)
Cost-effectiveness model: (2022-2023)
Cost-effectiveness model: (2019-2022)
Cost-effectiveness model: (2022-2025)
Published in the Journal of Medical Internet Research, 2025: Jan 29;27:e65974
Published online in JAMA Network Open, 2024: 7;(9):e2431715